The dissemination of medical information online in real time has forever changed the relationship between today's physician and patient. The idea that accurate and meaningful information can only flow in one direction is now extinct.
How can physicians take advantage of social media (SM)-in the form of online forums, microblogs (eg, Twitter), video, blogs, social networks, and podcasts1-as an opportunity to engage with patients and improve their care?
Here to discuss is Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, in Rochester, Minn. Dr Timimi can be found on Twitter at @FarrisTimimi.
Social Media in Medicine
Take home points
• SM is an opportunity for physicians to change community outcomes and improve patient care
• Because the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient
• SM is a logical extension of clinical practice, research, and education
• Content curation and content creation have “profound value” to patients and caregiver, so it is incumbent upon physicians to develop and review their organizational SM policy guide1
Reference
1. Timimi FK. Medicine, morality and health care. BMC Med. 2012;10:83.
Social Media and Medicine: A Winning Combination
Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, discusses the potential of social media to change the landscape of clinical practice.
The dissemination of medical information online in real time has forever changed the relationship between today's physician and patient. The idea that accurate and meaningful information can only flow in one direction is now extinct.
How can physicians take advantage of social media (SM)-in the form of online forums, microblogs (eg, Twitter), video, blogs, social networks, and podcasts1-as an opportunity to engage with patients and improve their care?
Here to discuss is Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, in Rochester, Minn. Dr Timimi can be found on Twitter at @FarrisTimimi.
Social Media in Medicine
Take home points
• SM is an opportunity for physicians to change community outcomes and improve patient care
• Because the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient
• SM is a logical extension of clinical practice, research, and education
• Content curation and content creation have “profound value” to patients and caregiver, so it is incumbent upon physicians to develop and review their organizational SM policy guide1
Reference
1. Timimi FK. Medicine, morality and health care. BMC Med. 2012;10:83.
RAD 2025: What You May Have Missed
Explore key insights from the 2025 Revolutionizing Atopic Dermatitis meeting, featuring expert interviews and the latest treatment advancements.
The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.
Novo's GLP-1/Amylin Dual Agonist Amycretin to Enter Late-Stage Trials for Obesity
Both oral and subcutaneous formulations of the long-acting GLP-1 and amylin receptor agonist move into stage 3 clinical trials following positive feedback from regulators.
The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship
Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.
GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose
Your daily dose of the clinical news you may have missed.
Q&A: JAK Inhibitor Safety in Context and the Rich Atopic Dermatitis Pipeline, with Leon Kircik, MD
RAD 2025: Renowned AD investigator Kircik provides the history behind the class-wide black box warning, highlights JAK inhibitor efficacy, and toplines exciting AD research.
RAD 2025: What You May Have Missed
Explore key insights from the 2025 Revolutionizing Atopic Dermatitis meeting, featuring expert interviews and the latest treatment advancements.
The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.
Novo's GLP-1/Amylin Dual Agonist Amycretin to Enter Late-Stage Trials for Obesity
Both oral and subcutaneous formulations of the long-acting GLP-1 and amylin receptor agonist move into stage 3 clinical trials following positive feedback from regulators.
The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship
Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.
GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose
Your daily dose of the clinical news you may have missed.
Q&A: JAK Inhibitor Safety in Context and the Rich Atopic Dermatitis Pipeline, with Leon Kircik, MD
RAD 2025: Renowned AD investigator Kircik provides the history behind the class-wide black box warning, highlights JAK inhibitor efficacy, and toplines exciting AD research.